Safety and immunogenicity of UB-612 heterologous booster in adults primed with mRNA, adenovirus, or inactivated COVID-19 vaccines: a randomized, active-controlled, Phase 3 trial. - Rumyantsev A; Wang L; Wang S; Kemp T; Wriggins A; Burks A; Fisher D; Brokke K; Fix A; Hensley S; Lewis M; Zhu R; et al. (EClinicalMedicine, 2025)